MapLight Therapeutics Cash Flow Statement (2024-2025) | MPLT

Cash Flow Statement Sep2024 Dec2024 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -19.81M-21.88M-29.95M-80.91M
Depreciation and Depletion (Quarter) 0.20M0.20M0.10M0.14M
Share-based Compensation (Quarter) 0.35M0.21M0.12M35.52M
Gains from Sales and Divestitures (Quarter) 1.69M
Gains from Investment Securities (Quarter) -1.54M0.93M0.27M
Non-cash Items (Quarter) 12.49M4.12M0.85M
Cash from Operations (Quarter) -21.49M-46.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.41M1.44M
Depreciation & Amortization (CF) (Quarter) 0.20M0.20M0.10M0.14M
Change in Working Capital
Change in Account Payables (Quarter) -0.16M0.89M
Change in Accured Expenses (Quarter) 1.21M1.12M
Investing Activities
Capital Expenditures (Quarter) 0.11M0.38M
Change in Acquisitions & Divestments (Quarter) 32.50M24.00M
Cash from Investing Activities (Quarter) 32.39M-242.55M
Financing Activities
Other financing activities (Quarter) 0.02M3.89M
Change in Capital Stock
Shares Issued (Quarter) 0.02M0.17M
Preferred Shares Issued (Quarter) 200.00M200.00M
Misc.
Cash from Financing Activities (Quarter) 0.01M271.96M
Change in Cash (Quarter) 10.91M-17.42M
Free Cash Flow (Quarter) -21.59M-47.20M
Net Cash Flow (Quarter) 10.91M-17.42M